Early research (Phase 1)Study completedNCT02161796
What this trial is testing
Evaluate the Dose-proportionality and Effects of FG-4592 in Healthy Young and Elderly Male and Female Subjects
Who this might be right for
PK for FG-4592Healthy Subjects
Astellas Pharma Europe B.V. 48